IRIS
CILIBERTO, GENNARO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.738
AS - Asia 6.859
EU - Europa 2.251
SA - Sud America 1.959
AF - Africa 142
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 20
Totale 21.993
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.395
SG - Singapore 3.134
CN - Cina 1.598
BR - Brasile 1.553
IT - Italia 891
VN - Vietnam 820
IN - India 705
SE - Svezia 420
GB - Regno Unito 386
CA - Canada 230
DE - Germania 175
HK - Hong Kong 162
AR - Argentina 161
BD - Bangladesh 85
MX - Messico 73
EC - Ecuador 71
ID - Indonesia 67
ZA - Sudafrica 53
IQ - Iraq 51
FI - Finlandia 47
JP - Giappone 45
RU - Federazione Russa 45
NL - Olanda 44
CO - Colombia 42
CL - Cile 39
UA - Ucraina 37
PL - Polonia 33
PY - Paraguay 33
ES - Italia 29
VE - Venezuela 29
MA - Marocco 26
TR - Turchia 24
SA - Arabia Saudita 22
RO - Romania 21
AU - Australia 17
FR - Francia 17
PK - Pakistan 17
UZ - Uzbekistan 17
KE - Kenya 16
PE - Perù 15
AE - Emirati Arabi Uniti 14
IR - Iran 14
CZ - Repubblica Ceca 13
EG - Egitto 13
EU - Europa 12
IE - Irlanda 12
UY - Uruguay 11
JO - Giordania 10
LT - Lituania 10
AL - Albania 8
AT - Austria 8
DZ - Algeria 8
GR - Grecia 8
JM - Giamaica 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
CH - Svizzera 7
NP - Nepal 7
BG - Bulgaria 6
HN - Honduras 6
IL - Israele 6
NZ - Nuova Zelanda 6
SN - Senegal 6
BO - Bolivia 5
KZ - Kazakistan 5
MY - Malesia 5
PH - Filippine 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BB - Barbados 4
BY - Bielorussia 4
CY - Cipro 4
EE - Estonia 4
PS - Palestinian Territory 4
BE - Belgio 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
KH - Cambogia 3
KR - Corea 3
LB - Libano 3
MD - Moldavia 3
NI - Nicaragua 3
NO - Norvegia 3
QA - Qatar 3
RS - Serbia 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
MK - Macedonia 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
SI - Slovenia 2
Totale 21.970
Salva come PNG Salva come JPEG
Città #
San Jose 1.836
Chandler 1.195
Dallas 1.045
Ashburn 828
Singapore 796
Santa Clara 619
Hefei 580
Bengaluru 579
Milan 521
Princeton 499
Lawrence 495
Chicago 338
London 302
Ho Chi Minh City 298
Wilmington 295
Beijing 187
Hanoi 169
Ottawa 165
Hong Kong 157
Des Moines 154
Boardman 136
São Paulo 134
Munich 123
Los Angeles 74
Shanghai 63
New York 54
Rome 53
Guangzhou 47
Council Bluffs 45
Pune 43
Norwalk 42
Rio de Janeiro 40
Haiphong 37
Turku 36
Tokyo 35
Brooklyn 34
Catanzaro 34
The Dalles 34
Brasília 33
Da Nang 30
San Francisco 30
Porto Alegre 27
Belo Horizonte 26
Boston 26
Curitiba 26
Columbus 25
Guayaquil 25
Warsaw 25
Campinas 24
Redmond 23
Wuhan 23
Baghdad 22
Hải Dương 22
Johannesburg 22
Montreal 22
Quito 22
Redwood City 22
Naples 21
Atlanta 20
Biên Hòa 20
Mexico City 20
Ninh Bình 20
Stockholm 20
Asunción 19
Buenos Aires 19
Dhaka 19
Amsterdam 18
Chennai 18
Thái Bình 18
Salvador 17
Shenzhen 17
Assago 16
Falls Church 15
Tashkent 15
Charlotte 14
Guarulhos 14
Jakarta 14
Manaus 14
Nairobi 14
Phoenix 14
Seattle 14
Thái Nguyên 14
Washington 14
Bắc Ninh 13
Can Tho 13
Santo André 13
Cape Town 12
Orem 12
Wuxi 12
Ann Arbor 11
Ha Long 11
Helsinki 11
Maceió 11
Manchester 11
Rui'an 11
Bauru 10
Jinan 10
Petrópolis 10
Sorocaba 10
Toronto 10
Totale 13.226
Salva come PNG Salva come JPEG
Nome #
The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2 483
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study 97
ADENOVIRAL VECTORS ENCODING ERYTHROPOIETIN AND THEIR USE IN GENE THERAPY 84
Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition. 81
59. Structural characterization of a biologically active human Lipocortin 1 expressed in Escherichia coli 80
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro 74
A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and non-hepatic origin 74
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 74
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 73
A novel method for site-directed mutagenesis: its application to an eukaryotic tRNAPro gene promoter 72
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines 72
A novel minigene scaffold for therapeutic cancer vaccines 71
ADENOVIRAL VECTORS FOR MUTANTS OF HUMAN INTERLEUKIN 6 (HIL-6) WITH HIL-6 ANTAGONIST ACTIVITY, PHARMACEUTICAL COMPOSITIONS THEREWITH AND THEIR USES 71
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT 71
T-CELL PEPTIDE EPITOPES FROM CARCINOEMBRYONIC ANTIGEN, IMMUNOGENIC ANALOGS, AND USES THEREOF 70
A fast and sensitive colorimetric assay for IL-6 on hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP) 69
A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice 69
A prokaryotic tRNA Tyr gene,inactive in Xenpous Laevis oocytes, is activated by recombination with an eukaryotic tRNA Pro gene 68
Monitoring of melanoma clinical progression by circulating NK and T cells immunoprofiling: a potential role for CCR7 in metastatic spread 67
A Multimeric Synthetic Combinatorial peptide library. A Multimeric Synthetic Combinatorial peptide library 67
RHESUS EPITHELIAL CELL ADHESION MOLECULE, NUCLEIC ACID ENCODING THE SAME, AND USES THEREOF 66
Interleukin 6 deficient mice are protected from bone loss caused by estrogen depletion 66
A functionally orthogonal estrogen Receptor-based transcription switch Tightly controlled by a non-steroid synthetic ligand 66
Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs 64
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) 64
Analysis of T and Natural Killer cells immune response in Ipilimumab treated 64
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses 63
Adenovirus-mediated gene transfer of a human IL-6 antagonist 63
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells 63
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent 62
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer 62
ANTAGONISTS OF HUMAN INTERLEUKIN-6 THAT ARE TOTALLY INCAPABLE OF BINDING GP 130, AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOUNDS 60
CHIMERIC BIOMARKER FOR THE EARLY DIAGNOSIS AND IMMUNOTHERAPY OF CANCER 59
A federated learning system for precision oncology in Europe: DigiONE 58
PREPARATION OF RECOMBINANT ADENOVIRUS CARRYING A REP GENE OF ADENO-ASSOCIATED VIRUS 58
Cancer stem cells and the slow cycling phenotype: How to cut the gordian knot driving resistance to therapy in melanoma 58
Phenotype characterization of human melanoma cells resistant to dabrafenib 57
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope 57
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave? 57
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance 56
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 56
An improved helper-dependent adenoviral vector allows persistent gene expression after i.m. delivery and overcomes pre-existing immunity to adenovirus 56
MicroRNAs regulate resistance to target therapy in melanoma 56
Liver failure and defective hepatocyte regeneration in Interleukin-6 deficient mice 56
Inhibition of Stearoyl-Coa desaturase 1 (SCD1) enzymatic activity reverts BRAFi and MEKi-induced selection of cancer stem cells in BRAF-mutated malignant melanoma 56
MUTANT INTERLEUKIN 6 WITH IMPROVED BIOLOGICAL ACTIVITY OVER WILD INTERLEUKIN 6 56
Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system 55
Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling 55
miR-579-3p controls melanoma progression and resistance to target therapy 55
ANTI-TUMOUR PHARMACEUTICAL COMPOSITIONS CAPABLE OF REDUCING DRUG RESISTANCE IN TUMOUR CELLS 55
HORMONE-DEPENDENT FORMS OF THE ADENO-ASSOCIATED VIRUS, REP PROTEINS, DNA SEQUENCES CODING FOR THEM, VECTORS CONTAINING THEM, AND REGULATORY METHODS OF THEIR INTRACELLULAR ACTIVITY 55
WT1 CpG islands methylation in human lung cancer: a pilot study 55
B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells 55
The emerging role of cancer cell plasticity and cell-cycle quiescence in immune escape 55
PROGRESS AND PROSPECTS: TRANSCRIPTION REGULATORY SYSTEMS 54
Monovalent phage display of human Interleukin (hIL)-6: selection superbinder variants for a complex molecular repertoire in hIL-6 D-Helix 54
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 54
Liver specific expression of cloned human genes 54
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study 53
Intratumor RNA interference of cell cycle genes slows down tumor progression 53
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas 53
In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist 53
Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial 53
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 53
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience 53
IMMUNOTHERAPY AGAINST ERBB-3 RECEPTOR 52
INTERLEUKIN-6 (IL-6) ANTAGONISTS 52
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome 52
Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells 51
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients 51
DNA sequence of a pseudogene for human C-reactive protein 51
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016 51
Regulation of C-reactive protein, haptoglobin and hemopexin gene expression 51
Interleukin-6 an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells 51
The reciprocal interplay between miR-579-3p and MITF controls melanoma proliferation and resistance to target therapy 51
RECOMBINANT VECTORS DERIVED FROM ADENO-ASSOCIATED VIRUS SUITABLE FOR GENE THERAPY 51
Pyrvinium pamoate induces death of triple-negative breast cancer stem-like cells and reduces metastases through effects on lipid anabolism 51
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth 50
A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas 50
Liver-Specific –Alpha 2 Interferon Gene Expression Results in Protection from Induced Hepatitis 50
CARCINOEMBRYONIC ANTIGEN FUSIONS PROTEINS AND USES THEREOF 50
Involvement of the Arg179 in the active site of human IL-6 50
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives 50
T-cell agonists in cancer immunotherapy 50
Apoptotic cell death in disease-Current understanding of the NCCD 2023 50
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions 49
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I: a model for stunted growth in children with chronic inflammation 49
CD8+ T CELL TOLERANCE CAN BE BROKEN BY AN ADENOVIRUS VACCINE WHILE CD4+ T CELL TOLERANCE IS BROKEN BY ADDITIONAL CO-ADMINISTRATION OF A TOLL-LIKE RECEPTOR LIGAND 49
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer 49
B4GALT1 as a New Biomarker of Idiopathic Pulmonary Fibrosis 48
Leptin receptor-mediated regulation of cholinergic neurotransmitter phenotype in cells of central nervous system origin 48
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma 48
Deducing the functional characteristics of the human selenoprotein SELK from the structural properties of its intrinsically disordered C-terminal domain 48
Epigenetic Changes Induced by Green Tea Catechins are Associated with Prostate Cancer 48
RHESUS HER2/NEU, NUCLEOTIDES ENCODING SAME, AND USES THEREOF 48
RHESUS CARCINO EMBRYONIC ANTIGEN, NUCLEOTIDES ENCODING SAME, AND USES THEREOF 48
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop 48
Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway. 48
Telomerase Reverse Transcriptase Fusion Protein , Nucleotides Encoding it, and uses thereof 48
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 47
Totale 6.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 234.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.487
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 26 4 18
2021/20221.332 20 5 9 316 114 27 60 287 119 153 211 11
2022/20233.544 1.002 62 32 348 446 333 1 259 605 201 212 43
2023/20241.420 349 215 129 79 63 380 49 22 16 24 43 51
2024/20254.729 788 408 184 150 173 601 76 197 702 255 303 892
2025/202610.779 446 1.433 1.553 2.313 992 304 1.360 562 1.447 369 0 0
Totale 22.317